An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method

Journal of Clinical Psychiatry

Volumn 72, Issue 9, 2011, Pages 1222-1228

  Gurrera, Ronald J ^a   Caroff, Stanley N ^b,c   Cohen, Abigail ^b   Carroll, Brendan T ^c,d   DeRoos, Francis ^b,c   Francis, Andrew ^e   Frucht, Steven ^f   Gupta, Sanjay ^g,h   Levenson, James L ⁱ   Mahmood, Ahsan ^h,j,v   Mann, Stephan C ^k,l   Policastro, Michael A ^m,n   Rosebush, Patricia I ^o   Rosenberg, Henry ^p,q   Sachdev, Perminder S ^r,s   Trollor, Julian N ^r   Velamoor, Varadaraj R ^t   Watson, Charles B ^u   Wilkinson, Jayne R ^b,c  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d OHIO UNIVERSITY   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g STATE UNIVERSITY OF NEW YORK   (United States)

^h UNIVERSITY AT BUFFALO   (United States)

ⁱ VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Buffalo Psychiatric Center   (United States)

^k University of Louisville School of Medicine   (United States)

^l Central Montgomery Mental Health and Mental Retardation Center   (United States)

^m WRIGHT STATE UNIVERSITY   (United States)

ⁿ GOOD SAMARITAN HOSPITAL   (United States)

^o MCMASTER UNIVERSITY   (Canada)

^p SAINT BARNABAS MEDICAL CENTER   (United States)

^q Malignant Hyperthermia Association of the United States   (United States)

^r UNIVERSITY OF NEW SOUTH WALES   (Australia)

^s PRINCE OF WALES HOSPITAL   (Australia)

^t WESTERN UNIVERSITY   (Canada)

^u BRIDGEPORT HOSPITAL   (United States)

^v INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ADRENERGIC SYSTEM; ANESTHESIST; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DELPHI STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EXPOSURE; EMERGENCY MEDICINE; HUMAN; HYPERTHERMIA; MEDICAL EXPERT; MEDICAL SPECIALIST; MENTAL DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PSYCHIATRIST; REFERENCE VALUE; RIGIDITY; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TACHYPNEA; WITHDRAWAL SYNDROME;

EID: 80053024231     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06438     Document Type: Article

References (29)

1. Kurlan R, Hamill R, Shoulson I. Neuroleptic malignant syndrome. Clin Neuropharmacol. 1984;7(2):109-120. doi:10.1097/02826-1984060-01 PubMed (Pubitemid 14050758)
2. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142(10):1137-1145. PubMed (Pubitemid 16223648)
3. Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry. 1986;143(12):1587-1590. PubMed (Pubitemid 17196204)
4. Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry. 1986;143(10):1227-1233. PubMed (Pubitemid 16008704)
5. Harsch HH. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases. J Clin Psychiatry. 1987;48(8):328-333. PubMed (Pubitemid 17138131)
6. Friedman JH, Davis R, Wagner RL. Neuroleptic malignant syndrome: the results of a 6-month prospective study of incidence in a state psychiatric hospital. Clin Neuropharmacol. 1988;11(4):373-377. doi:10.1097/02826-198080-06 PubMed
7. Warner MD, Peabody CA, Boutros NN. A survey of neuroleptic malignant syndrome. J Nerv Ment Dis. 1990;178(10):664-665. doi:10.1097/05053-19010-010 PubMed (Pubitemid 20378889)
8. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77(1):185-202. PubMed (Pubitemid 23066804)
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
10. Sachdev P, Mason C, Hadzi-Pavlovic D. Case-control study of neuroleptic malignant syndrome. Am J Psychiatry. 1997;154(8):1156-1158. PubMed (Pubitemid 27328837)
11. Adityanjee, Mathews T, Aderibigbe YA. Proposed research diagnostic criteria for neuroleptic malignant syndrome. Int J Neuropsychopharmacol. 1999;2(2):129-144. doi:10.1017/S146145790138 PubMed
12. Sachdev PS. A rating scale for neuroleptic malignant syndrome. Psychiatry Res. 2005;135(3):249-256. doi:10.1016/j.psychres.205.05.03 PubMed (Pubitemid 40984616)
13. Gurrera RJ, Chang SS, Romero JA. A comparison of diagnostic criteria for neuroleptic malignant syndrome. J Clin Psychiatry. 1992;53(2):56-62. PubMed
14. Linstone HA, Turoff M. The Delphi Method: Techniques and Applications. Reading, MA: Addison-Wesley; 1975. Reproduced in pdf format in 2002 and available free of charge at http://is.njit.edu/pubs/delphibook/.
15. Dalkey NC. Delphi. P-3704. Santa Monica, CA: RAND Corporation; 1967.
16. Brown BB. Delphi Process: A Methodology Used for the Elicitation of Opinions of Experts. P-3925. Santa Monica, CA: RAND Corporation; 1968.
17. Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol. 2005;5(1):37-48. doi:10.186/1471-28-5-37 PubMed
18. Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994;80(4):771-779. doi:10.1097/0542-194040-08 PubMed (Pubitemid 24128939)
19. Graham B, Regehr G, Wright JG. Delphi as a method to establish consensus for diagnostic criteria. J Clin Epidemiol. 2003;56(12):1150-1156. doi:10.1016/S0895-4356(03)021-7 PubMed (Pubitemid 37532800)
20. SurveyMonkey. User Manual: Customer Guide for Account Navigation, Survey Creation, Distribution & Analysis. http://s3.amazonaws.com/ SurveyMonkeyFiles/UserManual.pdf. Verified April 6, 2011.
21. Scheibe M, Skutsch M, Schofer J. Experiments in Delphi methodology. In: Linstone HA, Turoff M, eds. The Delphi Method: Techniques and Applications, Chapter IV.C. Reading, MA: Addison-Wesley; 1975:257-281.
22. Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998;2(3):i-iv, 1-88. PubMed
23. Levinson DF, Simpson GM. Neuroleptic-induced extrapyramidal symptoms with fever: heterogeneity of the 'neuroleptic malignant syndrome.' Arch Gen Psychiatry. 1986;43(9):839-848. PubMed (Pubitemid 16050206)
24. Fink M, Taylor MA. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009;66(11):1173-1177. doi:10.101/archgenpsychiatry.209.141 PubMed
25. Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry. 1989;146(6):717-725. PubMed (Pubitemid 19149581)
26. Fink A, Kosecoff J, Chassin M, et al. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984;74(9):979-983. doi:10.2105/AJPH.74.9.979 PubMed (Pubitemid 14059576)
27. McKee M, Priest P, Ginzler M, et al. How representative are members of expert panels? Qual Assur Health Care. 1991;3(2):89-94. PubMed
28. Dalkey NC. The Delphi Method: An Experimental Study of Group Opinion. RM-5888-PR. Santa Monica, CA: RAND Corporation; 1969.
29. Milholland AV, Wheeler SG, Heieck JJ. Medical assessment by a Delphi group opinion technic. N Engl J Med. 1973;288(24):1272-1275.